Access Resources
5501 - 5510 of 7540 Results
Title
Year
- 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study2017RESTRICTEDTitle: 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter studyJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 4Start Page: 622End Page: 634Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25060Best OA location URL: https://escholarship.org/content/qt01j9450z/qt01j9450z.pdf?t=p9ufqpCitation Count: 145
-
RESTRICTEDTitle: A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-SynucleinJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 4Start Page: 1107End Page: 1119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-017-0544-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-017-0544-9.pdfCitation Count: 47
- Evaluating community health workers' attributes, roles, and pathways of action in immigrant communities2017RESTRICTEDTitle: Evaluating community health workers' attributes, roles, and pathways of action in immigrant communitiesJournal Name: Preventive MedicinePublisher: Elsevier BVVol: 103Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ypmed.2017.07.020Best OA location URL: https://europepmc.org/articles/pmc6354577?pdf=renderCitation Count: 33
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial2017RESTRICTEDTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Best OA location URL: https://europepmc.org/articles/pmc5831666?pdf=renderCitation Count: 508
- Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's disease2017RESTRICTEDTitle: Minimal clinically important difference of the Modified Fatigue Impact Scale in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 43Issue #:Start Page: 101End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.016Citation Count: 16
-
RESTRICTEDTitle: Motor subtype changes in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 43Issue #:Start Page: 67End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.07.018Best OA location URL: https://europepmc.org/articles/pmc5842811?pdf=renderCitation Count: 55
- Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form2017RESTRICTEDTitle: Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric formJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 106Issue #:Start Page: 191End Page: 204Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.07.007Best OA location URL: https://europepmc.org/articles/pmc5793922?pdf=renderCitation Count: 27
- Predictors of anxiety in early-stage Parkinson's disease – Results from the first two years of a prospective cohort study2017RESTRICTEDTitle: Predictors of anxiety in early-stage Parkinson's disease – Results from the first two years of a prospective cohort studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 43Issue #:Start Page: 49End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.06.024Best OA location URL: https://cris.maastrichtuniversity.nl/files/76216595/Leentjens_2017_Predictors_of_anxiety_in_early.pdfCitation Count: 29
- The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders2017RESTRICTEDTitle: The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disordersJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 157Issue #:Start Page: 212End Page: 229Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2016.01.006Best OA location URL: https://europepmc.org/articles/pmc5848468?pdf=renderCitation Count: 25
-
RESTRICTEDTitle: Ubiquitin Linkage-Specific Affimers Reveal Insights into K6-Linked Ubiquitin SignalingJournal Name: Molecular CellPublisher: Elsevier BVVol: 68Issue #: 1Start Page: 233End Page: 246.e5Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.molcel.2017.08.020Best OA location URL: http://www.cell.com/article/S1097276517306172/pdfCitation Count: 153